The course formally known as SPARK Co-Lab Design closes its applications on Sunday…
It’s long been known that Australians are pretty good at innovating, but pretty poor at commercialising those innovations.
Imagine you’re a medical researcher, developing a break through medical device, but you have little knowledge or experience in how to bring this to market. This course is for you…
2018 Perth Biodesign course
Officially launched last Wednesday at CERI featuring talks from alumni as well as world leading burns specialist and medtech entrepreneur, Dr Fiona Wood, the course has a new name for the course (previously known as the SPARK Co-Lab Design).
The course is run by Accelerating Australia and SPARK Co-Lab. Information sessions for the new course got underway last month, and applications close this Sunday (8 April), with the course commencing on Monday 11 June.
So why the name change?
“The (new) name reflects the close alignment of the program with the biodesign methodology from Stanford University that the SPARK Co-Lab Design Course was based on,” Associate Professor Kevin Pfleger told Startup News, “(This) helps strengthen the relationship with the global biodesign community, and underscores the new level of partnership between Accelerating Australia and SPARK Co-Lab in running the course.”
Thanks to newly renewed funding from MTPConnect, the Perth Biodesign course will be rolled out nationally this year, beginning with Adelaide in May.
Applications for Perth Biodesign are open now.
Perth Biodesign runs as a six-month program, based on the Stanford Biodesign methodology and adapted to Australia.
Participants operate within a team of at least one clinician, engineer, business professional or scientists, with a maximum of five people per team. The course begins with a clinical immersion designed to teach participants how to identify clinical unmet needs and develop a compelling business case to meet this need.
The teams prioritise a particular unmet need and then develop new device concepts to fit the market and intellectual property landscape. During the second part of the course, teams develop their business strategy, covering IP, product development, regulatory affairs, reimbursement, funding and commercialisation.
Perth Biodesign works with a network of over 70 professionals who provide input into these projects.
“We’re looking to recruit doctors, scientists, engineers and people already working in a general business role, as well as senior-level medical, science, engineering and business students who are excited about entrepreneurship and want to be involved in a translational medical technology start-up.” Kevin said, “We want to find participants who are collaborative, creative, passionate and diligent.”
The video below shows Dr Kath Giles (Brandon Capital/Spark Co-Lab) talking about the 2017 course: